Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients
This is a retrospective study. 21 patients with known case primary/recurrent breast carcinoma (BIRADS 4/5 breast lesions) underwent [ 18F]FCH PET/CT prior to biopsy. Histopathological examination (HPE) is obtained and dichotomized into malignant and benign groups and HER2-ve and HER2+ve groups....
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
International Agency Energy Agency (IAEA)
2024
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/120520/ http://psasir.upm.edu.my/id/eprint/120520/1/120520.pdf |
| _version_ | 1848868196114759680 |
|---|---|
| author | Zakaria, Mohd Hazeman Ahmad Saad, Fathinul Fikri Shaharuddin, Shazreen Kamaluddin, Nor Rizan Esa, Ezalia Mat Yusoff, Yuslina |
| author_facet | Zakaria, Mohd Hazeman Ahmad Saad, Fathinul Fikri Shaharuddin, Shazreen Kamaluddin, Nor Rizan Esa, Ezalia Mat Yusoff, Yuslina |
| author_sort | Zakaria, Mohd Hazeman |
| building | UPM Institutional Repository |
| collection | Online Access |
| description | This is a retrospective study. 21 patients with known case primary/recurrent breast carcinoma (BIRADS 4/5 breast lesions) underwent [
18F]FCH PET/CT prior to biopsy. Histopathological
examination (HPE) is obtained and dichotomized into malignant and benign groups and HER2-ve and
HER2+ve groups. Maximum standardized uptake value (SUVmax (g/dl) was used to predict two
groups of variables for cellular breast cancer aggressiveness. QOL assessed SF-36®, SF36v2®, SF-
1,2® and SF-12v2® Health Surveys. Questionnaires used under Medical Outcome Trust and QOL
domains: Global Health Status (GHS), Physical Function (PF), Role Function (RF) and Social
Function (SF). |
| first_indexed | 2025-11-15T14:48:32Z |
| format | Conference or Workshop Item |
| id | upm-120520 |
| institution | Universiti Putra Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-15T14:48:32Z |
| publishDate | 2024 |
| publisher | International Agency Energy Agency (IAEA) |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | upm-1205202025-10-29T07:00:51Z http://psasir.upm.edu.my/id/eprint/120520/ Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients Zakaria, Mohd Hazeman Ahmad Saad, Fathinul Fikri Shaharuddin, Shazreen Kamaluddin, Nor Rizan Esa, Ezalia Mat Yusoff, Yuslina This is a retrospective study. 21 patients with known case primary/recurrent breast carcinoma (BIRADS 4/5 breast lesions) underwent [ 18F]FCH PET/CT prior to biopsy. Histopathological examination (HPE) is obtained and dichotomized into malignant and benign groups and HER2-ve and HER2+ve groups. Maximum standardized uptake value (SUVmax (g/dl) was used to predict two groups of variables for cellular breast cancer aggressiveness. QOL assessed SF-36®, SF36v2®, SF- 1,2® and SF-12v2® Health Surveys. Questionnaires used under Medical Outcome Trust and QOL domains: Global Health Status (GHS), Physical Function (PF), Role Function (RF) and Social Function (SF). International Agency Energy Agency (IAEA) 2024 Conference or Workshop Item NonPeerReviewed text en http://psasir.upm.edu.my/id/eprint/120520/1/120520.pdf Zakaria, Mohd Hazeman and Ahmad Saad, Fathinul Fikri and Shaharuddin, Shazreen and Kamaluddin, Nor Rizan and Esa, Ezalia and Mat Yusoff, Yuslina (2024) Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients. In: International Conference On Hybrid Imaging (IPET 2024), 7-11 Oct. 2024, Vienna, Austria. (pp. 574-575). |
| spellingShingle | Zakaria, Mohd Hazeman Ahmad Saad, Fathinul Fikri Shaharuddin, Shazreen Kamaluddin, Nor Rizan Esa, Ezalia Mat Yusoff, Yuslina Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients |
| title | Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients |
| title_full | Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients |
| title_fullStr | Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients |
| title_full_unstemmed | Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients |
| title_short | Novelty of 18F–fluorocholine computed tomography (18-FCHPETCT) in predicting quality of life in malignant breast cancer patients |
| title_sort | novelty of 18f–fluorocholine computed tomography (18-fchpetct) in predicting quality of life in malignant breast cancer patients |
| url | http://psasir.upm.edu.my/id/eprint/120520/ http://psasir.upm.edu.my/id/eprint/120520/1/120520.pdf |